Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

How loss of tumor suppressor drives ER+ breast cancer to metastasize to the bone

A Baylor College of Medicine-led team has uncovered how loss of tumor suppressor neurofibromin (NF1) in estrogen receptor-positive (ER+) breast cancer cells drives the cells' preference to metastasize to bone.

How loss of tumor suppressor drives ER+ breast cancer to metastasize to the bone

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Friday 21 August →